HK Stock Market Move | CH OVS G OCEANS (00081) rose nearly 4% in October, with contract sales totaling 5.05 billion yuan, an increase of 57.9% year-on-year.
China Overseas Grand Oceans Group (00081) rose by nearly 4%, as of the time of writing, it increased by 3.7%, to 2.24 Hong Kong dollars, with a turnover of 13.3059 million Hong Kong dollars.
CH OVS G OCEANS (00081) rose nearly 4%, closing at a 3.7% increase, at HK$2.24, with a turnover of HK$133.059 million.
On the news front, CH OVS G OCEANS announced that in October 2024, the companies in the Zhonghai Hongyang series (the company and its subsidiaries (group) and the group's affiliated and joint venture companies) achieved contract sales of RMB 5.05 billion and a contract sales area of 430,900 square meters, representing a year-on-year increase of 57.9% and 58.5% respectively.
For the period from January to October 2024, the cumulative contract sales amounted to RMB 31.456 billion and the contract sales area was 2.7586 million square meters, representing a year-on-year decrease of 16.4% and 12.0% respectively. As of the end of October 2024, the cumulative unsold subscription amount was RMB 0.892 billion and the unsold subscription area was 71,700 square meters.
Related Articles

Hong Kong stock concept tracking | Listed securities companies' performance in the first three quarters significantly increased, with market valuation possibly balanced (with concept stocks attached)

The preliminary price range for the H-share issuance of CNGR Advanced Material (300919.SZ) has been set at HK$34.00 to HK$37.80.

CSTONE PHARMA-B(02616): ACAAI 2025 | CS2015 (OX40L/TSLP bispecific antibody) made its first international academic appearance.
Hong Kong stock concept tracking | Listed securities companies' performance in the first three quarters significantly increased, with market valuation possibly balanced (with concept stocks attached)

The preliminary price range for the H-share issuance of CNGR Advanced Material (300919.SZ) has been set at HK$34.00 to HK$37.80.

CSTONE PHARMA-B(02616): ACAAI 2025 | CS2015 (OX40L/TSLP bispecific antibody) made its first international academic appearance.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


